Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan : A multicenter retrospective study
| Errataetall: |
CommentOn: J Infect. 2020 Oct;81(4):e18-e25. - PMID 32634459 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:81 |
|---|---|
| Enthalten in: |
The Journal of infection - 81(2020), 5 vom: 10. Nov., Seite e3-e5 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ishii, Makoto [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 09.11.2020 Date Revised 23.03.2021 published: Print-Electronic CommentOn: J Infect. 2020 Oct;81(4):e18-e25. - PMID 32634459 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jinf.2020.08.052 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314921508 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314921508 | ||
| 003 | DE-627 | ||
| 005 | 20231225153803.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jinf.2020.08.052 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1049.xml |
| 035 | |a (DE-627)NLM314921508 | ||
| 035 | |a (NLM)32920063 | ||
| 035 | |a (PII)S0163-4453(20)30590-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ishii, Makoto |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan |b A multicenter retrospective study |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.11.2020 | ||
| 500 | |a Date Revised 23.03.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: J Infect. 2020 Oct;81(4):e18-e25. - PMID 32634459 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Japan | |
| 650 | 4 | |a Retrospective study | |
| 650 | 4 | |a Risk factors | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Terai, Hideki |e verfasserin |4 aut | |
| 700 | 1 | |a Kabata, Hiroki |e verfasserin |4 aut | |
| 700 | 1 | |a Masaki, Katsunori |e verfasserin |4 aut | |
| 700 | 1 | |a Chubachi, Shotaro |e verfasserin |4 aut | |
| 700 | 1 | |a Tateno, Hiroki |e verfasserin |4 aut | |
| 700 | 1 | |a Nakamura, Morio |e verfasserin |4 aut | |
| 700 | 1 | |a Nishio, Kazumi |e verfasserin |4 aut | |
| 700 | 1 | |a Koh, Hidefumi |e verfasserin |4 aut | |
| 700 | 1 | |a Watanabe, Risa |e verfasserin |4 aut | |
| 700 | 1 | |a Ueda, Soichiro |e verfasserin |4 aut | |
| 700 | 1 | |a Terashima, Takeshi |e verfasserin |4 aut | |
| 700 | 1 | |a Suzuki, Yusuke |e verfasserin |4 aut | |
| 700 | 1 | |a Yagi, Kazuma |e verfasserin |4 aut | |
| 700 | 1 | |a Miyao, Naoki |e verfasserin |4 aut | |
| 700 | 1 | |a Minematsu, Naoto |e verfasserin |4 aut | |
| 700 | 1 | |a Inoue, Takashi |e verfasserin |4 aut | |
| 700 | 1 | |a Nakachi, Ichiro |e verfasserin |4 aut | |
| 700 | 1 | |a Namkoong, Ho |e verfasserin |4 aut | |
| 700 | 1 | |a Okamori, Satoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Ikemura, Shinnosuke |e verfasserin |4 aut | |
| 700 | 1 | |a Kamata, Hirofumi |e verfasserin |4 aut | |
| 700 | 1 | |a Yasuda, Hiroyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Kawada, Ichiro |e verfasserin |4 aut | |
| 700 | 1 | |a Hasegawa, Naoki |e verfasserin |4 aut | |
| 700 | 1 | |a Fukunaga, Koichi |e verfasserin |4 aut | |
| 700 | 0 | |a Keio COVID-19 Research Consortium (K-CORC) and the Keio Donner Project Team |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 81(2020), 5 vom: 10. Nov., Seite e3-e5 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
| 773 | 1 | 8 | |g volume:81 |g year:2020 |g number:5 |g day:10 |g month:11 |g pages:e3-e5 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2020.08.052 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 81 |j 2020 |e 5 |b 10 |c 11 |h e3-e5 | ||